Regenerative effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) after sequestrectomy of medication-related osteonecrosis of the jaw (MRONJ)

OBJECTIVES: Beyond the original application approved by the U.S. Food and Drug Administration, recombinant human bone morphogenetic protein-2 (rhBMP-2) is used for medication-related osteonecrosis of the jaw (MRONJ) treatment because of its bone remodeling enhancement properties. The purpose of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Song-Hee, Kang, No-Eul, Song, Seung-Il, Lee, Jeong-Keun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Oral and Maxillofacial Surgeons 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338633/
https://www.ncbi.nlm.nih.gov/pubmed/32606280
http://dx.doi.org/10.5125/jkaoms.2020.46.3.191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338633/
https://www.ncbi.nlm.nih.gov/pubmed/32606280
http://dx.doi.org/10.5125/jkaoms.2020.46.3.191

Ejemplares similares